West Nile virus epizootics in the Camargue (France) in 2015 and reinforcement of surveillance and control networks C. Bahuon (1) , C. Marcillaud-Pitel (2) , L. Bournez (3) , A. Leblond (2, 4, 5) , C. Beck (1) , J. Hars (6) , I. Leparc-Goffart (7) , G. L'Ambert (8) , M.-C. Paty (9) , L. Cavalerie (10) , C. Daix (2) , P. Tritz (2, 11) , B. Durand (12) , S. Zientara (1) Sentinel veterinarians reporting suspect cases to the RESPE neurological syndrome sub-network proceed with standardised sampling protocols: two serum blood collection tubes, plus two etylenediaminetetra- . Mortality was monitored in wild birds that have been described as the most sensitive to WNV infection, e.g. corvids, passerids and turdids (order Passeriformes) and species of the order Falconiformes (8, 9) (Fig. 1a) . Surveillance was reinforced in wild birds in early September, allowing dead birds from the selected families to be collected through SAGIR, as soon as one specimen was found dead or moribund. Dead birds were shipped to local veterinary laboratories for systematic autopsy and brain, heart, spleen and liver sampling. Organs from the birds were stored at -80°C and shipped frozen to ANSES for analysis. (12) , as well as by flavivirus Luminex assay, as described by Beck et al. (11) . Given the long persistence of anti-WNV IgG antibodies in horses, a horse found positive by competition ELISA but negative by IgM capture ELISA was regarded as an unconfirmed case, but assumed to be carrying markers of previous infection (or vaccination). acetic acid (EDTA) whole blood collection tubes, or one nasopharyngeal swab, or one CSF sample. In addition to such sampling protocols, veterinary practitioners reporting directly to local Veterinary Services can send one serum and one EDTA whole blood collection tube to local laboratories. In order to identify and confirm WNV infections in live animals, indirect serological diagnostic tools are primarily used (7) . Blood was systematically sampled in serum collection tubes from suspect equine clinical cases, allowed to clot at ambient temperature and centrifuged at 1,500-2,900 g for a maximum of 10 min before the serum was collected. Sera were stored at +4°C for one month at most, or at -20°C for long-term archiving.
Vector surveillance

Reporting of West Nile virus human suspect cases
The surveillance of WNV infections in humans at countrywide level (Fig. 1b) In addition, active surveillance, both retrospective and prospective, is triggered as soon as WNV infection is detected in humans or animals (equines or birds). In 2015, once the first two equine WNV cases had been notified, a retrospective survey was conducted in hospitals from Bouches-du-Rhône and Gard departments with the aim of identifying suspect patients that had not been tested for WNV.
Samples were obtained from human patients with neurological symptoms (meningitis, encephalitis, polyradiculoneuritis). Blood samples in serum and EDTA collection tubes, as well as CSF samples whenever possible, were sent to the hNRL for WNV diagnostics. Serum was processed as previously described for equine samples, while EDTA blood and CSF were stored at -20°C until analysis.
West Nile virus surveillance in wild birds
Surveillance was carried out in Mediterranean departments at risk for WNV circulation from May to October through the SAGIR network, which is a network for the epidemiological surveillance of wildlife diseases set up Organs of wild birds suspected of WNV disease were ground in tubes containing 1 ml Dulbecco' s Modified Eagle' s Medium (Invitrogen, Thermo Fisher Scientific) and ceramic beads (Lysing Matrix D, MP Biomedicals) and placed into a ribolyser. Extraction of RNA was performed on an aliquot of 250 µl of the obtained supernatant with the RNeasy mini-kit (Qiagen, Hilden, Germany), while the residual supernatant was stored at -80°C for isolation assays. The RNA extracts were screened at ANSES for the presence of WNV genomic RNAs by real-time RT-PCR on Applied Biosystems thermocyclers (Foster City, California, USA), as described by Linke et al. (13) . Diagnostic tests performed at IRBA on human samples consist of an identical real-time RT-PCR protocol for the detection of the WNV genome (13) and in-house ELISAs (indirect IgG and MAC-ELISAs) using precipitated and inactivated virus (14) .
Mosquito samples were analysed at IRBA for WNV genome detection. Mosquito pools (≤50 mosquitoes/pool) were crushed by mechanical homogenisation in 500 µl-1 ml phosphate-buffered saline-bovine serum albumin 3%. The RNA extraction was performed with a QIAamp viral RNA mini-kit (Qiagen, Hilden, Germany), according to the manufacturer' s recommendations. The real-time RT-PCR for the detection of WNV genomic RNAs was performed as previously described (13) .
Results
West Nile virus epizootics in 2015
By 17 November 2015, through the implementation of initial ELISA tests and MAC-ELISA in local veterinary laboratories, as well as confirmatory serological tests at ANSES, 39 equine outbreaks had been confirmed in three departments surrounding the Camargue area, namely Bouches-du-Rhône, Gard and Hérault (Fig. 3) . In the outbreak area, 65 animals exhibited meningoencephalitis. Serological tests for WNV ruled out WNV aetiology in 24 equines (four animals with WNV IgG only and 20 animals with no WNV antibody response). In total, 49 equines were found to be infected with WNV (positive in WNV competition and MAC-ELISAs, as well as in WNV VNT); among them, 41 exhibited a neuroinvasive form, three a mild febrile form and five were asymptomatic. The five asymptomatic infections were identified through systematic screening of all the equines from three recognised outbreaks and through retrospective analysis of equine sera collected in the vicinity of the outbreaks. Neuroinvasive forms of WNV in equines were observed between 11 August and 30 October. Six equines died or were euthanised subsequent to severe WNV neuroinvasive disease and prolonged decubitus; this corresponds to a case fatality rate of 14.6% (6/41).
Equine outbreaks of WNV were mainly located in the Camargue area, on the border of the Bouches-du-Rhône and Gard departments (Fig. 3 ). They were centred in a 60-km-diameter circle between the communes of SaintesMaries-de-la-Mer in the south, Boulbon in the north, Salon de Provence in the east and Milhaud in the west. Only one remote case was reported in Hérault department (50 km away from the nearest outbreak in Gard), in a horse with no travel history. Outbreaks of WNV were described as early as 
Early detection of West Nile virus cases in horses
West Nile virus has been monitored through the RESPE neurological syndrome sub-network for more than five years. Unusual increases in the reporting of neurological syndromes to RESPE can be readily detected. Through analysis of monthly reports submitted to the RESPE neurological syndrome sub-network from 2011 to 2014, notifications were shown to peak in autumn and early winter, from October to January (with six to eight reports each month, on average, while for the rest of the year three to six cases per month were generally observed), when EHV-1 outbreaks are also most frequently detected (Fig. 5) . However, in 2013 and 2015, remarkably high numbers of neurological syndromes were reported in July-August and September, respectively. Although the neurological cases that occurred in summer 2013 were investigated, WNV and EHV-1 aetiologies were not confirmed, and no other pathogens, and in particular no arbovirus, could be identified through extensive molecular screening of available samples (next-generation sequencing, RNA array).
However, in 2015, WNV infections were rapidly detected through the RESPE network. The first two WNV cases were reported to RESPE on 17 August, identified at LABEO Frank Duncombe Laboratory as WNV IgM-positive on 26 August and confirmed at ANSES on 29 August. Signs of meningoencephalitis were manifest in both horses: ataxia, convulsions, alertness or behavioural modifications, hyperaesthesia and decubitus were described and had started on 11 August and 17 August. After confirmation of the first two WNV cases, the RESPE network immediately informed every SV about WNV circulation in France, encouraging veterinary practitioners to be more vigilant for neurological signs in horses and to report suspect cases to Veterinary Services. An increase in the number of reports in September 2015 probably reflects the enhanced vigilance of equine veterinary practitioners (Fig. 5, arrow) .
While ensuring early detection of WNV and participating in the sensitisation of SVs to WNV circulation in the Camargue area, it is important to note that RESPE registered a total of only 26 clinically suspect cases in August-October 2015, quite uniformly distributed throughout France, including three confirmed WNV cases (Fig. 6a) . After confirmation of the first WNV cases, most horses in south-eastern France suspected of having meningoencephalitis were not analysed through the RESPE network but were reported directly to local Veterinary Services (75 suspect cases reported to local Veterinary Services only, versus nine suspect cases reported through RESPE). They were mostly located in the three departments with confirmed WNV cases (Bouches-duRhône, Gard and Hérault) (Fig. 6b) .
Coordination and reinforcement of West Nile virus surveillance activities in France
As soon as the first equine WNV cases had been confirmed, the French national Veterinary Services (Direction Générale de l'Alimentation [DGAl]) informed the numerous contributors to WNV surveillance in equines, humans, wild avifauna and vectors through a telephone conference organised on 31 August. Animal surveillance was reinforced, with DGAl, the French National Society of Veterinary Technical Groups and ONCFS/FNC prompting veterinarians and the SAGIR network to increase vigilance for WNV-induced disease or mortality in horses and wild birds, respectively (on 2 and 4 September). Even though SAGIR was rapidly informed of WNV circulation in the Camargue, only 12 dead birds were reported in the area from July to October 2015, and none of them tested positive for WNV, a situation similar to that described during the 2000 and 2004 WNV outbreaks in the region.
Updated information on equine outbreaks of WNV was shared with WNV surveillance contributors on a weekly or bi-weekly basis on the ESA platform (a French platform for animal epidemiological surveillance [www.plateforme-esa. fr]) and the RESPE Internet site (www.respe.net). A WNV management unit was rapidly implemented on the initiative of the DGAl, in order to evaluate animal surveillance data and to gain insight into the extent of WNV circulation through the establishment of a dedicated prospective survey.
West Nile virus surveillance was also rapidly strengthened in humans and mosquito vectors, under the guidance of the Ministry of Health. The usual enhanced surveillance of West Nile neuroinvasive disease in humans, implemented on 1 June, identified 96 suspect cases, all of which were negative for WNV. Once the first two equine WNV cases had been notified, a retrospective survey was conducted in hospitals in the Bouches-du-Rhône and Gard departments from August to September 2015 to identify patients presenting with unexplained meningitis or encephalitis and not tested for WNV. No WNV infection was diagnosed among the 71 patients identified. 
Discussion
The 2015 WNV transmission season in France was characterised by intense and localised WNV amplification cycles associated with equine WNV neuroinvasive cases. It is, however, difficult to fully infer the amplitude and distribution of WNV circulation in 2015 without implementing specific serosurveys in animals or in humans (15, 16) , because most WNV infections are asymptomatic in infected mammals (17) . In total, 49 WNV infections were confirmed in equines (positive IgM response), including 41 animals with meningoencephalitis, which corresponds to the third most important WNV epizootic reported in France. West Nile virus had been described in the Camargue area as early as 1962, when at least 50 cases with neurological signs were observed (5). More recently, in 2000, the largest WNV epizootic ever reported in the Camargue occurred from August to early November, with 131 suspect cases presenting with meningoencephalitis, 58 confirmed (positive IgM response), 18 probable infections (positive IgG response only) and 21 deaths (18) . At the end of summer 2004, another WNV epizootic was reported in an area close to the 2015 WNV outbreaks, with 57 suspect cases in horses, 32 confirmed cases and seven deaths (6) . The case fatality rate of 14.6% during the 2015 WNV epizootic was found to be much lower than usually reported (20-57%) (19) . Such findings could be attributed to the low pathogenicity of the circulating WNV strain(s) (analysis in progress), to improved therapeutic measures implemented by equine veterinarians or to enhanced vigilance of practitioners; the last hypothesis is supported by the fact that horses with mild neurological signs (rare stumbling events, for example) were reported and tested using WNV diagnostic tests. It is interesting to note that no abnormal fatalities in wild birds were observed in the Camargue in 2015, a situation similar to that reported in the most recent French WNV outbreaks and in European outbreaks due to lineage 1 WNV strains (20) . Moreover, no severe neuroinvasive forms were described in humans.
Disease control mainly relied on informing the public on how to reduce mosquito populations (essentially through destruction of mosquito breeding sites) and limit exposure of animals to mosquito bites. Entomological investigation identified ponds and water tanks that were breeding sites for Culex pipiens and Culex modestus, and those which could not be emptied were treated with Bti (Bacillus thuringiensis serovar israelensis, Bt H-14). Since 2009, inactivated or recombinant vaccines have been made available for use in equines in Europe. In France, animal vaccination is performed upon the request of horse owners, and apparently only a small proportion of equines from the Camargue were vaccinated during the outbreak (ongoing investigation). Equine WNV surveillance allowed early detection of WNV infections in 2015, as it did during the previous French outbreaks. In Europe, modelling WNV circulation has indicated that clinical surveillance in horses is a costeffective and sensitive system (24) . With reporting of every suspect equine case, identification of the first WNV-positive clinical cases in horses should precede the identification of WNV in mosquitoes or of seroconversion events in birds or horses by a few days, and, at a maximum, two weeks. However, in practice, in countries endemic for WNV such as Italy or Greece, early detection or assessment of WNV spread is usually achieved by vector or sentinel bird surveillance (25, 26) .
In 2015, the first two equine cases were reported through the RESPE network, while clinically suspect cases detected subsequently were more readily reported to local Veterinary Services. The two reporting systems appeared to be complementary. The RESPE network, which was created in 1999, was the first network of its kind in Europe. Since 2008 it has become an independent association connecting the equine medicine and industry sectors, and has been recognised as essential for the detection, followup and control of equine diseases at the national and international levels (iRESPE initiative). In particular, it ensures comprehensive surveillance of infectious diseases that cause major economic losses for the equine industry or pose significant risks to public health (zoonotic pathogens). Besides providing support, differential diagnostics and epidemiological information, RESPE also facilitates the submission of samples for WNV diagnostics, and thus enables WNV surveillance. Indeed, following the 2000 French WNV outbreaks, during which strict control measures had been implemented in the Camargue, including banning horse movements and equestrian events, many horse owners were reluctant to report WNV cases. Therefore, RESPE has been useful in maintaining a minimum level of vigilance in the Camargue area. The RESPE neurological syndrome sub-network should also enable more effective and rapid monitoring for encephalitis-causing endemic or emerging pathogens through syndromic surveillance (27 
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